Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group. Kuhlen M, Kunstreich M, Eilsberger F, Lorenz K, et al. Eur Thyroid J 2025;14:e250035.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kuhlen M, Kunstreich M, Eilsberger F, Lorenz K, et al. Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group. Eur Thyroid J 2025;14:e250035.
PMID: 40736768